NEWS RELEASECOMPLETION OF FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARESMay 22, 2023
EditForce, Inc. (Head Office: Fukuoka; President and CEO: Takashi Ono) announces that we have raised
a total of 300 million yen through a third-party allotment of new shares to FFG Venture No. 3 Investment
Limited Partnership, SMBC Venture Capital No. 7 Investment Limited Partnership, and Fukuoka Jisho Co.,Ltd.
As a result of this round of financing, we have completed ¥2.1 billion in funding together with the previous
fund-raising in March of this year.
Takashi Ono, President and CEO, commented, "The fact that we have received support again since theyear of 2021 from the venture capital of Fukuoka Financial Group, Inc., and that Fukuoka Jisho Co,, Ltd.
and the venture capital of the Sumitomo Mitsui Banking Corporation Group, which is a major financialgroup, have chosen us as an investment destination shows high evaluation for the innovativeness andfuture potential of our proprietary RNA editing technologies. We would like to firmly meet such expectation."
We will use the funds raised through this recent third-party allocation to promote our existing pipeline andexpand our R&D activities to improve our basic technologies and build new pipelines, striving to deliver
our technology-based pharmaceuticals to patients suffering from genetic diseases as soon as possible.

About EditForce:
EditForce, Inc., a Kyushu University-originated start-up developing a unique DNA/RNA editing technology(PPR platform technology*), was established in May 2015 by KISCO Co., Ltd. and Prof. Takahiro
Nakamura of Kyushu University (former president of EditForce and currently its scientific advisor) andfunded by companies and funds that have track records of investing in life sciences and biotechnology.
EditForce aims for drug discovery that applies the PPR technology through joint research with universities
and private companies.
For more information, please visit https://www.editforce.co.jp/*Pentatricopeptide repeat (PPR) protein platform technology
PPR is a protein discovered in plants that regulates gene expression by binding to DNA and RNA ina sequence-specific manner. The PPR proteins are also found in humans and yeasts, and they have
similar functions. Professor Takahiro Nakamura and Dr. Yusuke Yagi, CTO of EditForce, havefocused on the PPR proteins and elucidated the mechanism that determines sequence specificity,and established a technology for creating various PPR proteins, each of which binds to a specifictarget DNA or RNA sequence. Furthermore, it is possible to manipulate and modify the target genome
and RNA both inside and outside the cell by fusion with effector proteins.

About FFG Venture No. 3 Limited Partnership:
FFG Venture 3 Investment Limited Partnership is a venture capital fund managed by FFG Venture CapitalBusiness Partners Co., Ltd. FFG Venture Capital Business Partners Co., Ltd., as a venture capital under
the umbrella of Fukuoka Financial Group, supports startups that contribute to the revitalization of regional
economies and the creation of new industries. We invest not only in Kyushu, but also in domestic andoverseas cutting-edge startups. At the same time, our purpose is to contribute to the business growth oflocal companies by bridging startups to the Kyushu economy.
For more information, please visit http://www.ffg-venture.co.jp/

About SMBC Venture Capital No. 7 Limited Partnership:
SMBC Venture Capital No. 7 Investment Limited Partnership is a venture capital fund managed by SMBC
Venture Capital Co., Ltd. SMBC Venture Capital Co., Ltd. is a long-established domestic VC that has been
investing in start-up companies for more than 20 years, and it conducts investments from a long-term
perspective. We have contact points with a variety of companies that support venture companies, such as
auditing firms, securities companies, and other investors, and we will provide support using these networks.
As a member of the Sumitomo Mitsui Financial Group, a comprehensive financial group, we provide
seamless support in line with the growth stage through the Group’s global network and comprehensivestrengths.

For more information, please visit https://www.smbc-vc.co.jp/

About Fukuoka Jisho Co., Ltd.:As a community-rooted developer, Fukuoka Jisho Co., Ltd. has engaged in the planning and development
of office buildings, retail facilities, condominiums, hotels, and logistics facilities with the idea of "making
Fukuoka more interesting."
In order to enhance the attractiveness of towns, Fukuoka Jisho believes that we need not only to attract
companies and human resources from both domestic and overseas, but also to support start-up
companies and make them from local companies to global ones, and it has participated in the operationof Fukuoka Growth Next, a public-private, collaborative startup support facility, since 2017. It also invests
in FGN ABBALab Fund, a venture-capital firm based in Fukuoka Growth Next, and start-ups originatingfrom Kyushu University.
For more information, please visit https://fukuokajisho.com/ .